Pharmanectar

Pharmanectar is a Brazilian biotechnology company specializing in the research, development, and production of high-quality bee-derived products, particularly Green Propolis. The company leverages proprietary extraction technologies to standardize bioactive compounds like Artepillin C for use in nutraceuticals, pharmaceuticals, and cosmetics. Pharmanectar maintains a strong focus on scientific validation, collaborating with academic institutions to explore the therapeutic potential of propolis in immunology, oncology, and infectious diseases. Their business model encompasses the entire value chain, from sustainable raw material sourcing to the manufacturing of finished health products for global markets. The company is recognized for its rigorous quality control and its role in establishing international standards for propolis-based therapeutics.